This inventor holds 2 USPTO granted patents. Top assignee: University of Michigan. Active years: 2016-2018.
Company Filing History:
Years Active: 2016-2018
Title: Innovations by Daniel L. Albertus
Introduction
Daniel L. Albertus is an accomplished inventor based in Ann Arbor, MI. He has made significant contributions to the field of medical technology, particularly in the diagnosis and measurement of retinal diseases. With a total of 2 patents, his work has the potential to greatly enhance patient care and diagnostic accuracy.
Latest Patents
One of his latest patents is titled "Automated measurement of changes in retinal, retinal pigment epithelial, or choroidal disease." This innovative method involves retrieving a set of fundus images and selecting a plurality of images from that set. The images are co-registered and pre-processed to ensure similar quality, contrast, and gain. A comparison is then made to determine changes in retinal diseases based on various metrics, ultimately generating a display for users on a computing device.
Another notable patent is "Systems and methods for diagnosing inherited retinal diseases." This method automatically diagnoses inherited retinal diseases by receiving various types of data and pre-processing them to create a feature vector descriptive of a patient. The process includes comparing data to a mutation proven database, generating a ranked list of matches, and aggregating these lists to provide a ranked list of genetic diagnoses to the end user.
Career Highlights
Daniel L. Albertus is affiliated with the University of Michigan, where he continues to advance his research and innovations in the field of retinal disease diagnostics. His work is characterized by a commitment to improving healthcare outcomes through technology.
Collaborations
Some of his notable coworkers include Kanishka T. Jayasundera and Christopher R. Ranella, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Daniel L. Albertus exemplifies the spirit of innovation in medical technology, with his patents paving the way for advancements in the diagnosis and treatment of retinal diseases. His contributions are invaluable to the field and hold promise for future developments.